DBV Technologies | DBVT - EPS Earnings Per Share


DBV Technologies reported $-0.55 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
DBV Technologies USD -0.55 0.31 Mar/2026
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Incyte USD -3.6 6.69 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026